Mane // 2021 CSR Report

Introduction

Chapter 1

Chapter 2

Chapter 3

Chapter 4

Chapter 5

Appendices

ENSURE PRODUCT SAFETY AND COMPLIANCE

It is impossible to separate the performance of our company and its acceptance by society from the reduction of the environmental impacts of our activities. Our goal is to better protect the communities and ecosystems around us. To reduce these impacts, we have made the following commitments: ■ ensure product safety and compliance; ■ reduce pollution and spills; ■ improve the energy eciency of our facilities and fight climate change; ■ integrate the concept of Green Chemistry into R&D; ■ reduce environmental impacts during production; ■ guarantee the safety and rational management of water; ■ effectively manage our waste to promote the circular economy; ■ preserve biodiversity and fight against deforestation.

They ensure that the finished products we supply to our customers are safe, of uniform and consistent quality, and satisfactory for consumer safety. The vast majority of the Group’s sites which manufacture food flavours are ISO 9001, IFS & BRC, FSCC 22000 or ISO 22000 certified, depending on the region. The manufacture of our finished products for the pharmaceutical industry (human or veterinary use) complies with Good Manufacturing Practices (GMP). These facilities are inspected by the French authorities. The fragrances and cosmetic ingredients that we manufacture are ISO 9001, EFfCI or ISO 22716 certified, depending on the site.

ENSURE THE HEALTH SAFETY OF OUR PRODUCTS

ASSESSING THE TOXICOLOGICAL SAFETY OF PRODUCTS

The quality and safety of products are legitimate expectations of and major concerns for our consumers. Guaranteeing the health and safety of our products by protecting the health and safety of consumers is therefore a challenge and a priority for MANE and its customers. Our approach covers the entire supply chain, starting with suppliers. We incorporate very strict controls in our purchasing and audit process, which allows us to select safe and high-quality raw materials. Audits are conducted at suppliers’ sites to verify their ability to meet MANE’s quality and safety requirements and identify any points of weakness. All our production sites have established quality and health safety management systems. These systems provide for procedures and methods established at the various stages of production (reception, control of work in progress, final control). The manufacture and control of our products therefore meet strict standards. Risk analyses reduce the risks of physical, chemical and microbiological contamination to an acceptable level. Associated monitoring plans are in place to ensure continuous control. Before the finished products leave our sites, we run tests to validate that they can be used safely. The tests carried out on finished products generally include physicochemical, microbiological and organoleptic tests.

As part of our innovation approach, the development of a new ingredient or a new technology is subject to a rigorous assessment process regarding safety and regulatory matters. The intrinsic properties of new products are assessed and serve as the basis for our safety assessment and hazard classification processes. Research projects are coordinated by a Scientific Committee whose members meet every quarter. During the innovation process, the environmental impact and animal welfare are also taken into account. This issue is of the utmost importance to MANE. The Group does not test its flavouring or fragrance compositions on animals. Moreover, no animal testing is carried out or ordered by MANE for its manufactured ingredients, unless otherwise required by national or regional regulations. Our commitment to avoid animal testing in all cases is also reflected in our commitment to finding alternative methods. Since 2007, we have ben shareholders of ImmunoSearch. This research company is dedicated to the development of in vitro toxicological tests. We also forge key partnerships with and/or take equity stakes in companies that are experts in non-animal experimentation methods, such as R&D companies developing QSAR models ( in silico methodology).

OUR CONTRIBUTION TO THE SDGS

26

2021 CSR REPORT ◆